MetaCap

Who Owns Sunshine Biopharma Stock?

NASDAQ: SBFMHealthcareDrug Manufacturers - Specialty & GenericUSD

0.43-0.27 (-38.57%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
6.42%
Institutional holders
12
  • Institutions 6.4%
  • Insiders 1.6%
  • Public and other 92.0%

Who owns Sunshine Biopharma stock?

Institutional investors own about 6.4% of Sunshine Biopharma's shares, spread across 12 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.59% of SBFM.

The largest institutional holders are Jane Street Group, LLC (0.35%), Morgan Stanley (0.01%) and SBI Securities Co., Ltd. (0.00%). Together, the top 9 institutions control 0.4% of shares outstanding. In their latest filings, 7 of the top 9 institutions increased their SBFM positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of SBFM

Sunshine Biopharma top institutional holders
InstitutionShares% HeldChange
Jane Street Group, LLC14.97K0.35%+100.0%
Morgan Stanley3850.01%-73.7%
SBI Securities Co., Ltd.1620.00%-11.5%
National Bank of Canada/FI/50.00%+400.0%
Osaic Holdings Inc.20.00%+100.0%
Farther Finance Advisors, Llc10.00%+100.0%
TD Waterhouse Canada Inc.10.00%+100.0%
Strive Financial Group , LLC10.00%+100.0%
Caitong International Asset Management Co., Ltd10.00%+100.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of SBFM

Sunshine Biopharma top fund holders
FundShares% Held
Fidelity NASDAQ Composite Index Fund110.00%

Frequently asked questions

Who is the largest shareholder of Sunshine Biopharma?

Jane Street Group, LLC is the largest institutional shareholder of SBFM, owning 0.35% of shares outstanding (14.97K shares) as of its latest 13F filing.

What percentage of Sunshine Biopharma is owned by institutions?

Institutions own about 6.4% of SBFM shares and 6.5% of the public float.

How much of Sunshine Biopharma do insiders own?

Insiders, such as officers and directors, own about 1.59% of SBFM shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related